Breathe Easy with Randox Clinical Laboratory Services
Respiratory tract infection (RTI) is defined as any infectious disease of the upper or lower respiratory tract. Some infections can affect the sinuses, throat, airways or lungs.1 Upper respiratory tract infections (URTIs) include the common cold, laryngitis, pharyngitis/tonsillitis, acute rhinitis, acute rhinosinusitis and acute otitis media.2Whereas lower respiratory tract infections (LRTIs) include acute bronchitis, bronchiolitis, pneumonia and tracheitis.2
Every five minutes someone dies from lung disease in the UK lung disease and are responsible for more than 700,000 hospital admissions and over 6 million inpatient bed-days in the UK each year. (BLF)3
The typical symptoms of respiratory tract infections include the following:4
- a cough – you may bring up mucus (phlegm)
- a stuffy or runny nose
- a sore throat
- muscle aches
- breathlessness, tight chest or wheezing
- a high temperature (fever)
- feeling generally unwell
The lungs are a vital organ to the human body as they keep us alive and functioning. Our bodies are designed to protect the lungs, keeping dirt and germs at bay. There are many tips on how to keep your lungs healthy to reduce the risk of developing lung disease or respiratory tract infections:
One of the main advices to reduce any sort of lung disease is to not smoke. Smoking cigarettes are the major cause of lung disease. Research have stated there is one in five deaths annually or 1,3000 deaths every day because of smoking.5 On average, smokers would have a shorter life span and die 10 years earlier. Cigarettes cause the air passages to narrow making breathing difficult.6 Overtime it will destroy the lung tissue which can result long-term illness such as cancer. It is also important to avoid second-hand smoking as even though the person isn’t physically smoking a cigarette they can still inhale the toxic chemicals from being near a smoker.
Minimize exposure to outdoor air pollution can improve lung health because certain air pollution can affect the lungs making it more difficult to breathe.6 Getting involved in regular exercise will strengthen the lungs and keep them healthy.
An important key point to prevent lung disease is to prevent infection. A simple cold can cause serious complications to the lungs. It is essential to take care of your hygiene by washing your hands regularly with soap and warm water to get rid of any bacteria. Avoid crowds during flu season and get vaccinated every year against influenzas. Finally, regular healthcare check-ups is essential to allow early diagnosis and treatment if needed.
Randox Clinical Laboratory Services (RCLS), provides a clinical laboratory service designed to meet the time sensitive, bespoke requirements of research and clinical projects globally. We provide a trusted and checked testing service as all our clinical laboratories hold numerous accreditation’s ensuring your patient samples are tested to the highest standard.
If your laboratory is outsourcing Respiratory testing, Randox Clinical Laboratory Services offers the Respiratory Multiplex Array with the ability to test your patient samples for you!
We detect 22 bacterial and viral pathogens from a single sample! Our experienced project management teams are available to provide support and guidance from initial biomarker selection through to the design of a comprehensive results data package to deliver against your project aims and timelines while you save money, time and labour.
The Evidence Investigator is a compact, semi-automated benchtop analyser which is renowned for its versatility, robustness and effective reporting methods. The Evidence Investigator has offered efficient and comprehensive testing in a wide range of laboratory settings for many years including, clinical diagnostics, molecular, research, toxicology and food diagnostics.
The Evidence Investigator is the perfect fit for medium throughput laboratories seeking maximum use of bench space and can process up to 44 results from a single sample, with a maximum throughput of up to 2376 tests per hour.
It is extremely well equipped to provide reliable and accurate results because results are generated using Charge Coupled Device (CCD) camera, which quantifies chemiluminescent light. The light then measures the degree of binding between the sample and specific biochip bound ligands. The Evidence Investigator image processing software translates light signal generated from chemiluminescent reactions into analyte concentrations which removes the need for any manual processing of data.
Our molecular product range offers diagnostic, prognostic and predictive solutions across a variety of disease areas including sexually transmitted infection (STI), respiratory tract infection, colorectal cancer, familial hypercholesterolemia (FH) and cardiovascular disease (CVD). Additionally, we can provide a wide range of assay formats including single nucleotide polymorphisms (SNP) genotyping, pathogen detection and mutation detection. The technology allows simultaneous detection of multiple analytes from a single sample for efficient and cost-effective testing.
STI and Respiratory Arrays
Sexually transmitted infections (STIs) affect more than 1 million people every day and each year 500 million new cases of STIs occur.1 Therefore, it is vital for early and accurate detection. Randox’s Sexually Transmitted Infections Multiplex Array simultaneously detects 10 bacterial, viral and protozoan including primary, secondary and asymptomatic co-infection for a complete infection profile. The assay is based on a combination of multiplex PCR and biochip array hybridisation. Innovative PCR priming technology permits high discrimination between multiple targets.
Respiratory tract infections are caused by many viral and bacterial pathogens and are the second most common cause of morbidity and mortality worldwide.2 The Respiratory Multiplex Array is the most comprehensive screening test for infections of both the upper and lower respiratory tracts, simultaneously detecting 22 bacterial and viral pathogens from a single sputum lavage or nasopharyngeal sample.
Both arrays detect the most common and frequently requested infections in sexual and respiratory health. These comprehensive, highly sensitive and specific tests enable identification of co-infections simultaneously, often in asymptomatic patients and enable antibiotic stewardship.
KRAS, BRAF, PIK3CA Array and Familial Hypercholesterolemia Arrays I & II
The colorectal cancer (CRC) is the third most common cancer worldwide. Overall, the lifetime risk of developing colorectal cancer is: about 1 in 22 (4.49%) for men and 1 in 24 (4.15%) for women.3 The KRAS, BRAF, PIK3CA Array simultaneously detects 20 point mutations within the KRAS, BRAF and PIK3CA genes. The assay is validated for use with the DNA extracted from fresh/frozen and formalin fixed paraffin embedded tissue. The array is CE marked for routine clinical use.
Familial Hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism. 4It is the most common autosomal dominant, or inherited disease and affects the plasma clearance of LDL-cholesterol, resulting in premature onset of cardiovascular disease and higher mortality risk.5 Early diagnosis is crucial as by the time the FH sufferer enters early adulthood they will have accumulated >20 years of continuous exposure to build up of fatty or lipid masses in the arterial walls and are at the hundred-fold greater risk of a heart attack than other young people. The Familial Hypercholesterolemia (FH) Arrays I & II are rapid, simple and accurate detection of 40 FH-causing mutations within the LDLR ApoB and PCSK9 genes.
These unique biochip assays permit high discrimination between multiple targets in several genes with a rapid turnaround time (3 hours). The arrays enable detection of the most frequently occurring mutations known to cause disease (FH) and adversely affect patient treatment (KRAS, BRAF, PIK3CA). A unique primer set is designed for each target which will hybridise to a complimentary oligo-nucleotide probe spotted on a biochip discrete test region (DTR).
Cardiovascular Risk Prediction Array
Coronary Heart Disease is the leading cause of death in the developed world and its prevention is a core activity for public health systems worldwide.6 Randox have the Cardiac Risk Prediction Array which will allow for 19 SNPs to be genotyped simultaneously, which incorporate a test to identify patients predisposed to statin-induced myopathy.
This array identifies individuals with a genetic predisposition to coronary heart disease (CHD). The innovative multiplex primers are designed to discriminate DNA sequences which differ only at one base.
For more information on our Evidence Series or Molecular range of Assays, contact us at firstname.lastname@example.org
Randox Clinical Laboratories Service (RCLS) has been built on 35 years of Randox Laboratories experience. The aim of our RCLS team is to meet the time sensitive, custom-made requirements of research and clinical projects. They specialize in biomarker and multiplex testing to provide full laboratory services to aid the project aims and timelines whilst saving time and money. Currently, there are four laboratories across the UK located in Liverpool, London, Holywood and the Randox Science Park in Antrim where knowledgeable and proficient teams are situated and are available accordingly to provide support and guidance.
Continuing with National Heart Month, RCLS would like to take the opportunity to reinforce the importance of taking care of your hearts health. (WHO) highlighted Ischemic heart disease and stroke are the world’s biggest killers. An estimated 17 million people die of cardiovascular disease particularly heart attacks and strokes every year.1
Lipoprotein (a) which is also known as Lp(a) consists of two protein molecules, apolipoprotein (a) or apo(a). It is a large lipoprotein particle made by the liver. The Apo(a) particle is a very sticky protein particle, thought to be involved in the clotting system and its addition can be likened to adding a patch of Velcro on to a normal LDL particle. 2 Having some cholesterol and Lp(a) in your blood is normal however, high levels of LDL cholesterol would increase your risk of having some serious heart implications.
It has been highlighted in recent research that blood levels of Lp(a) could be an important indication as it is currently the strongest inherited risk factor for developing cardiovascular disease and stroke. Globally, one in five people have high levels of Lp(a) greater than 50mg 3. As a result, gradually narrow the arteries, limiting blood supply to the brain, heart kidney, legs and can also increase the risk of blood clots, heart attack and stroke.
High Lp(a) can also be related to other common risks factors of cardiovascular diseases for example, smoking, diet, diabetes, high blood pressure and lack of exercise. Therefore, it is possible that those who appear “healthy” can have high Lp(a) in their genes and still be at high risk of cardiovascular diseases.
The Lipoprotein(a) Foundation strongly emphasized that the Lp(a) test would be advised if you have the following:
- If there is a family who has history with cardiovascular disease including stroke, heart attack, circulation problems in the legs and/or narrowing of the aorta, at a young age. If someone in your family has high Lp(a), their children have a 50/50 chance inheriting it.
- Stroke or heart attack are classical risk factors including high LDL-cholesterol, obesity, diabetes and smoking have been eliminated
- High levels of LDL-cholesterol following treatment with statins or other LDL lowering medications
Randox Clinical Laboratory Services offer you our Lipoprotein (a) assay as well as our variety of analysers across all RCLS laboratories including our RX Series and Evidence Series as well as third party analysers ensuring the testing abilities are diverse. The Randox Lp(a) assay is one of the only methodologies on the market that detects the non-variable part of the Lp(a) molecule providing accurate and consistent results.
If you would like more information on RCLS please contact email@example.com
There are many different science roles at Randox which require many different skillsets – and there are as many different pathways to get to them! One such pathway is the Higher Level Apprenticeship offered by Randox in collaboration with Northern and Southern Regional Colleges.
Sarah Casey is both a Randox Higher Level Apprentice and a student at Portadown Southern Regional College. We caught up with her fresh from her win at the Southern Regional College Science Competition in January 2019.
Sarah, congratulations on winning the science award at Southern Regional College!
Please tell us more about the Science Competition you took part in – and won – at Southern Regional College.
The competition was held at the SRC Newry Campus and consisted of two experiments. I competed against other students from Randox, Almac and Norbrook.
For the first experiment, I had to find the concentration of an unknown sample of copper sulphate. I carried out a serial dilution using a known concentration of copper sulphate and then found the absorbance of each of the standards. I then found the absorbance for the unknown sample as well. From this I was able to plot a graph and determine the concentration of the unknown sample.
For the second experiment, I had to carry out a titration of iodine against sodium thiosulphate. I added the sodium thiosulphate to the iodine solution until the solution appeared pale yellow. I added a few drops of the starch indicator and continued titrating until the solution appeared colourless. I recorded the titre and then repeated the titration two more times to find an average titre. I then had to complete several questions relating to this experiment.
What did you study before you applied for the Higher Level Apprenticeship?
I previously studied A-Levels at St. Joseph’s Grammar school, undertaking Biology, Chemistry and Digital Technology. I always had a keen interest in science when I was younger so after studying Biology and Chemistry for A-Level I knew that I wanted to pursue a career in this field. In school I enjoyed the practical aspect of subjects which lead me to want to take part in this Higher Level Apprenticeship.
Where are you currently studying and what do you like most about your course?
I am studying the Life Science pathway of Applied Industrial Science at Portadown Southern Regional College. This course is based on biology and I have just finished semester one. I enjoy learning about buffer solutions, oxidation and redox reaction. For semester two, I look forward to studying physiology and continue to gain more knowledge about biology.
How did you hear about Higher Level Apprenticeships at Randox?
I heard about the higher level apprenticeship from my Careers teacher at school. He highly recommended that we tried out for the apprenticeship. After I applied after carrying out some research online. I was then offered a place here at Randox and started in September 2018.
Could you give a brief description of a typical day at Randox for you?
At the moment, I am based in the QC Serum department carrying out value assignments for Randox products. On a typical day I will come into work and carry out the daily maintenance on the RX Daytona and Imola. I will then have a look through the assignment folder to check what lots need to be assigned a value. I will gather the calibrator, controls and test lots in order to reconstitute them. While they are rolling, I will collect the necessary reagents. The test is then carried out. Afterwards I will type up the results into a spreadsheet to check if the lots have passed. I can carry out nest tests, two-day assignments and calibrator validations for chemistrys, lipids and cardiac. In between runs, I check sheets that are sent to customers.
What qualifications will you have when your Higher Level Apprenticeship at Randox ends?
I will finish my apprenticeship in September 2020. Since joining Randox only a few months ago I have already gained so many invaluable skills. By the end of this apprenticeship I hope to be competent with most or all the analysers used at Randox while continuing to exhibit good laboratory practice. At the end of the apprenticeship I will gained a foundation degree in Applied Industrial Sciences. I can then progress onto year two of Biomedical Science at Ulster University.
Would you recommend a Higher Level Apprenticeship at Randox to someone else and why?
I would highly recommend the higher level apprenticeship. It is a great experience and provides all the necessary skills required to pursue a career in this industry. Also, it allows you to earn while you learn so it’s a win-win situation as a student!
For more information about Sarah’s story or to hear more about the Higher Level Apprenticeship at Randox, please contact RandoxPR@randox.com.
Do you have a flair for science? Are you an electronic, mechanical or software engineering expert? Or, perhaps, you are a mastermind of manufacturing know-how. There are world-leading careers on offer for world-leading candidates at Randox Teoranta in Dungloe this December.
That’s the message that global diagnostics firm Randox Teoranta wants to send to students, graduates and experienced professionals alike as it opens its doors to the public once again on Monday 24th December 2018.
Held from 9am to 12noon, the morning is an opportunity for those interested in science, engineering, software development and manufacturing roles in Donegal to have a tour of the state-of-the-art facility and chat with Randox Teoranta staff members about the careers on offer.
Randox Teoranta is particularly passionate about attracting back those who have left Ireland to find careers further afield due to lack of opportunities in their particular vocations. Dream careers in science, engineering and manufacturing are available on the doorstep in Dungloe.
Dr. Ciaran Richardson, Head of Research & Development at Randox Teoranta, commented;
“At Randox Teoranta, we’re constantly pushing the boundaries of healthcare and diagnostic capabilities, allowing us to offer world-class career opportunities in the heart of Donegal.
“Our scientists are working on a range of research projects which will lead to quicker diagnoses of conditions such as stroke, gastrointestinal disorders and chronic kidney disease. In 2016, our scientists even developed a pioneering new test to determine a patient’s risk of developing Alzheimer’s disease.
“There are also opportunities for software developers, electronic & embedded systems engineers, validation and mechanical engineers as our technology continues to advance to accommode our scientific breakthroughs.
“Our manufacturing department also boasts a number of competitive roles which are essential to Randox Teoranta’s continuation as a world leader in healthcare diagnostics and associated technology.
“There are fantastic career opportunities here in one of the most beautiful parts of the world – and the quality of life is second-to-none.”
There are a wide variety of career opportunities available at Randox Teoranta. From placement opportunities for college and university students to graduate roles in a variety of fields, young scientists and engineers have the opportunity to get their ‘big break’ on the career ladder with a globally-recognised company.
There are also opportunities for experienced and driven individuals looking for a smart career move. Randox Teoranta offer competitive salaries, career progression, personal development and the opportunity to work in a cutting-edge company paving the way in ground-breaking global health diagnostics.
Healthcare shouldn’t be one-size-fits-all. Neither should your career.
Randox Teoranta’s Open Morning will take place on Monday 24th December 2018 from 9:00 until 12:00 at Randox Teoranta, Meenmore, Dungloe, Co. Donegal.
Students, graduates and experienced professionals are welcome to visit along with their family and friends. Potential candidates are welcome to bring their CV on the day or email it to firstname.lastname@example.org.
Booking is not required, however, more information, including directions, can be found by searching Randox at www.eventbrite.ie.
More information about the open day can also be found by contacting +353 7495 22600 or emailing RandoxPR@randox.com.
The Randox Clinical Laboratories Services (RCLS) team strives to meet the time sensitive, custom-made requirements of research and clinical projects. Accordingly, RCLS is also able to provide support and guidance. They specialise in biomarker and multiplex testing which provide full laboratory services to aid project aims and timelines whilst saving time and money. Currently, there are four laboratories across the UK located in Liverpool, London, Holywood and the Randox Science Park in Antrim.
In 2017 approximately 422,000 diagnoses of STIs were made in England1 and over one million STIs are acquired every day 2.
Sexually transmitted infections (STIs) are a viral or bacterial infection passed from one person to another through unprotected sexual contact.3 Most STIs are curable however, it takes time for the symptoms to appear or show up in tests. Others have no cure, such as HIV, but can be treated to prevent the disease getting worse. Common symptoms of STIs include vaginal discharge, urethral discharge or burning in men, genital ulcers, and abdominal pain 2 although, a person can have an STI without having obvious symptoms of disease.
Randox Clinical Laboratory Services offers a multiplex sexually transmitted infection array allowing you to outsource sample STI testing. It includes common STIs such as Chlamydia, Gonorrhoea, Syphilis, Herpes Simplex I, Herpes Simplex II. The full Multiplex Array can be seen below.
The simultaneous detection is made possible by our award-winning and innovative Biochip Array Technology which utilises multiplex testing methodology in a rapid and accurate format. The type of sample which is sent to our RCLS lab is determined by the visibility of the symptoms. Non-visible symptoms will require a urine sample whereas visible symptoms will require a swab sample.
There are many benefits to outsourcing your STI samples with RCLS, which include the following:
- ISO17025 Accredited Laboratories
- Excellent precision, specificity, sensitivity and accuracy for diagnosis
- Reduced risk of false reporting and a reduced number of unnecessary tests
- Smaller sample volumes are required therefore enabling faster throughput and rapid patient diagnosis
STI Multiplex Array:
- Chlamydia trachomatis
- Neisseria gonorrhoea
- Herpes simplex 1
- Herpes simplex 2
- Treponema pallidum
- Mycoplasma hominis
- Ureaplasma urealticum
- Mycoplasma genitalium
- Haemophilius ducreyi
- Trichomonas vaginalis
If you would like more information on RCLS or our STI testing please contact email@example.com
Randox Clinical Laboratory Services (RCLS) utilises the expertise and knowledge that Randox has built up over 35 years producing high quality IVD products. We strive to provide a clinical laboratory service to meet the time sensitive, bespoke requirements of research and clinical projects globally.
Moving away from traditional single analyte assays, Biochip Array Technology (BAT) boosts cutting edge multiplex capabilities. Biochip Array Technology provides a unique platform for assessment of biological samples in a rapid, accurate and easy to use format and users can have the utmost confidence in this proven technology.
Our technology facilitates the simultaneous quantitative or qualitative detection of a wide range of analytes, providing a rapid and accurate diagnosis from a single patient sample. As well as having time and cost saving benefits, which drive towards an increase in clinical performance, testing for multiple markers given a more comprehensive picture of a patient’s condition.
By RCLS utilising the innovative Biochip Array Technology that Randox have created, we are able to avail the Evidence Evolution. The Evidence Evolution is the world’s first fully automated random access biochip testing platform. It sets new standards in diagnostic quality and efficiency to deliver precise results quickly and economically. With the capability to process up to 2,640 tests per hour, the Evidence Evolution offers complete system integration, as well as the most comprehensive multiplex test menu on the market.
Overall, the Evidence Evolution provides benefits that allows us to offer you a cost effective, labour saving and time reducing solution for your sample testing. Randox Clinical Laboratory Services also utilise the wide array of Randox analysers, both clinical and Immunoassay, several third party analysers are also used by RCLS.
To find out more information on what Randox Clinical Laboratory Services has to offer email us at firstname.lastname@example.org
Randox Laboratories and Ulster University have launched a £5 million skills development initiative to support up to 10 individuals annually through PhD level study in the Life Sciences sector.
The Randox-Ulster University-Industrial PhD Academy, which aims to encourage the development of advanced, higher level skills in key industry sectors, will further reinforce Ulster University’s position as one of the top universities for biomedical related research impact and, enhance Randox’s competitiveness in the growing global healthcare sector.
Up to ten PhD researchers will be supported annually, including Randox employees and individuals from the wider sector, who are working on a range of scientific projects, with the ultimate goal of new product development. They will have the opportunity to work on new research projects, driven by industry and jointly supervised by Ulster University and Randox, to enhance their own individual skill sets whilst delivering groundbreaking advances in the life sciences sector. Ulster University and Randox will each fully fund up to five PhD researchers annually.
To date PhD researchers enrolled in this new programme of Industrial Research have started exciting projects in areas of medicine including mental health, diabetes and cancer, with more projects being developed. All projects share the common goal of delivering new diagnostic approaches for early detection of disease and earlier intervention where possible.
Professor Alastair Adair Deputy Vice-Chancellor Ulster University said:
“Ulster University is renowned globally for research in personalised medicine, cancer, diabetes and mental health and this makes us the perfect fit for a global industry leader like Randox. Ulster University and Randox have a longstanding partnership built around research, knowledge sharing and collaboration which has placed both organisations at the forefront of diagnostics and health research globally.”
Ulster University Professor of Personalised Medicine Tara Moore, said:
“The life sciences sector is of critical importance to our economy and health. To truly maximise our contribution to the economy and to fully exploit new advances in science and technology we must focus on advancing the skills of our workforce, ensuring the most talented people reach their full potential by working with partners to tackle new challenges and drive new discoveries. A strong and growing life sciences sector ensures patients will continue to benefit from new technologies which will help to improve diagnosis getting them the treatment they need quickly.”
“This new Industrial PhD Academy is a further step forward in our commitment to respond to national priorities such as the Industrial Strategy, aligning the research community with industry to drive innovation, building on the world-leading reputation of Randox and supporting a new generation of researchers in this strategically important sector.”
Dr Peter FitzGerald, Managing Director of Randox Laboratories, said;
“At this time of rapid and significant change in the UK, it is critical that the next-generation can meet industry’s ever-changing demands. The current STEM skills shortage costs the economy £1.5bn/year and will only be resolved if all companies in the sector recognise they have a role to play now too.
“In the last 4 months, we have made significant investments within Northern Ireland, in both R&D infrastructure and now in helping aspirational scientists at Ulster University to develop the critical skills to make a positive difference to patient healthcare around the world. We are unapologetically ambitious in our determination to cement Northern Ireland’s reputation as a global hub for life sciences and our own position as a worldwide leader.”
For further information about the Randox UU PhD Academy please contact Randox PR by email: email@example.com or by phone: 028 9442 2413
An Ulster University marketing student has won the top spot in global healthcare manufacturer Randox Laboratories’ annual Student Placement Awards.
Matthew Steele from Bushmills fought off stiff competition from fellow placement students in science and engineering programmes by attracting the judges’ attention for the work he carried out within two new and novel ventures taken on by the company.
In recent years, the founder of Randox Laboratories, Dr Peter FitzGerald, has extended his business portfolio to include the Bushmills-based Dundarave Estate and Cherryvalley Farm in Crumlin. Matthew’s focus has been to develop and promote tourism activities at the Estate, such as clay pigeon shooting, as well as Cherryvalley Farm produce. He worked with the company’s IT department and Finance team to complete various projects and created a digital communications strategy.
Additionally, when Matthew was faced with the familiar catch-all that employees may find themselves asked to carry out additional tasks, he won plaudits within the company for stepping in to dip sheep on one occasion!
Speaking after the awards ceremony Matthew commented;
“Placement has been amazing for me and I would encourage everyone to do it. The year has gone so quickly, because you get thrown in straightaway. You’re not seen as a placement student – you’re a member of staff right from the start. This experience has given me so much, widening my business knowledge and teaching me so many new skills. It’s been great.”
Department winners in the engineering and science placement programmes are respectively Ulster University student Dale Love from Ballymena and Jamie Boyd, a Queen’s University Belfast student from Cookstown.
Across the company, 39 university students took part in this year’s placement programme. Lasting 50 weeks, the initiative provides young people with the experience needed to pursue a career in their chosen field.
Linda Magee, Head of Randox Human Resources, commented;
“We are delighted for all our winners in this year’s placement awards. Matthew, in particular, impressed us with creative and successful strategies, and the wholehearted approach he brings to working with us. The Randox Placement Programme is one of our most important initiatives, because gaining industry-experience is now critical for young people. Randox is committed to developing meaningful ways of supporting them, and we are encouraged year after year by the calibre of students who apply to join us.”
For further information about the Randox Placement Awards please contact Randox PR by email: firstname.lastname@example.org or by phone: 028 9442 2413
What is health care? When we think of caring for our health, we think of going to the doctor when we feel ill. The healthcare cycle we’re accustomed to is one where we wait for symptoms to present themselves and then we visit a doctor, hoping to be prescribed medication to limit our symptoms.
Is this really health care? Are we really caring for our bodies in the best way possible by waiting for illness to manifest itself? What if we could properly look after our bodies by taking action early to stop illness in its tracks?
The key to this is identifying indicators of pre-illness, and the technology that allows you to do this is now available directly to you through Randox Health.
After investing over £220 million in the invention and production of revolutionary blood-science technology, a single Randox Health check will deliver a complete picture of your health – as it is now and crucially how it is likely to develop in the future.
Randox Health has proven that signs of disease or irregularity can be caught at their earliest stage. This means that, with early action, some cases of illness can even be prevented altogether. Our health checks include, but are not limited to, cancer surveillance, fertility monitoring, heart health, nutrition, digestive and diabetes health.
In other words, from one health check, you’ll receive up to 350 results and afterwards avail of expert advice from the Randox scientists or a Randox Health GP. Not only that, but a complete 12-month programme and repeat testing come as standard so you can have full confidence that you are really taking care of yourself.
Look out for our new ‘Health Made Simple’ blogs beginning next week, where we’ll be delving in to the sophisticated science and diagnostic tests that power each Randox Health check.
You’ll find out about our Everyman, Everywoman and our Signature health checks, as well as our Specialised testing options which focus on specific health issues.
Find out more and start your Randox Health journey today.
For further information, please contact the Randox PR team via email: email@example.com or phone 028 9442 2413